One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis
Manal F. Abdelmalek MD, Stephen A. Harrison MD, Arun J. Sanyal MBBS
doi : 10.1111/dom.15524
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes
Jonah A. Hoyt BS, Emily Cozzi PhD, David A. D'Alessio MD, Chris C. Thompson MD, Vanita R. Aroda MD
doi : 10.1111/dom.15533
Practical strategies to manage obesity in type 2 diabetes
Helena W. Rodbard MD, Katharine Barnard-Kelly PhD, Andreas F. H. Pfeiffer MD, Carina Mauersberger PhD, Oliver Schnell MD, Francesco Giorgino MD
doi : 10.1111/dom.15556
The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes
David S. H. Bell MB, Terri Jerkins MD
doi : 10.1111/dom.15559
The Obese Taste Bud study: Objectives and study design
Alexander Kersten, Andrea Lorenz, Cita Nottmeier DMD, Michael Schmidt DMD, Anuschka Roesner DMD, Florian Christoph Richter MD, Kristin Röhrborn DPharm, A. Veronica Witte PhD, Sebastian Hahnel MD, Till Koehne MD, Matthias Blüher PhD, Michael Stumvoll PhD, Kerstin Rohde-Zimmermann PhD, Imke Schamarek MD
doi : 10.1111/dom.15563
Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes
Setor K. Kunutsor PhD, Victoria G. Balasubramanian PhD, Francesco Zaccardi PhD, Clare L. Gillies PhD, Vanita R. Aroda MD, Samuel Seidu MD, Kamlesh Khunti PhD
doi : 10.1111/dom.15511
Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
Xiaopeng Shao MSc, Jingyi Lu PhD, Rui Tao PhD, Liang Wu MD, Yaxin Wang MD, Wei Lu BSN, Hongru Li PhD, Jian Zhou PhD, Xia Yu PhD
doi : 10.1111/dom.15512
Low-grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators
Sidsel L. Domazet MSc, Thomas B. Olesen MD, Jacob V. Stidsen MD, Camilla K. Svensson MD, Jens S. Nielsen MSc, Reimar W. Thomsen MD, Niels Jessen MD, Peter Vestergaard MD, Mette K. Andersen MSc, Torben Hansen MD, Charlotte Brøns MSc, Verena H. Jensen MSc, Allan A. Vaag MD, Michael H. Olsen MD, Kurt Højlund MD
doi : 10.1111/dom.15514
Pharmacological treatment of obesity in adults in Norway 2004–2022
Paz Lopez-Doriga Ruiz MD, Øystein Karlstad PhD, Kjersti Nøkleby MD, Kristina Slåtsve MD, Hanne L. Gulseth MD, Haakon E. Meyer MD, Kari Anne Sveen MD, Elisabeth Qvigstad MD, Kari Furu PhD
doi : 10.1111/dom.15515
Real-world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide
Caroline Swift PhD, Monica Frazer PhD, Noelle N. Gronroos PhD, Andrew Sargent MS, Michael Leszko MPH, Erin Buysman MS, Sara Alvarez PharmD, Tyler J. Dunn PhD, Josh Noone PhD, Mico Guevarra MD
doi : 10.1111/dom.15516
Associations of a proinflammatory diet, habitual salt intake, and the onset of type 2 diabetes: A prospective cohort study from the UK Biobank
Wenqi Shen MD, Lingli Cai MD, Bin Wang PhD, Jiang Li PhD, Ying Sun MS, Yi Chen MD, Fangzhen Xia PhD, Ningjian Wang MD, Yingli Lu MD
doi : 10.1111/dom.15517
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Stefan R. Bornstein MD, Dick de Zeeuw MD, Hiddo J. L. Heerspink PhD, Friedrich Schulze PhD, Lisa Cronin MD, Arne Wenz Dipl.Biol., Katherine R. Tuttle MD, Samy Hadjadj MD, Peter Rossing DMSc
doi : 10.1111/dom.15518
Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta-regression analysis of 120 randomized controlled trials
Kris G. Vargas MD, Tobias Rütten MD, Benedikt Siemes MD, Maximilian Brockmeyer MD, Claudio Parco MD, Alexander Hoss MD, Sabrina Schlesinger PhD, Christian Jung MD, Michael Roden MD, Malte Kelm MD, Georg Wolff MD, Oliver Kuss PhD
doi : 10.1111/dom.15519
Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase
Yuliya Tishova MD, Svetlana Kalinchenko MD, George Mskhalaya MD, Geoffrey Hackett MD, Mark Livingston PhD, Carola König PhD, Richard Strange PhD, Michael Zitzmann PhD, Amar Mann MbChB, Amro Maarouf MbChB, Sudarshan Ramachandran PhD
doi : 10.1111/dom.15520
Accelerated onset of diabetes in non-obese diabetic mice fed a refined high-fat diet
Heidi M. Batdorf BS, Luz de Luna Lawes BS, Gabrielle A. Cassagne BS, Molly S. Fontenot BS, Innocence C. Harvey PhD, Jeremy T. Richardson BS, David H. Burk PhD, Samuel D. Dupuy BS, Michael D. Karlstad PhD, J. Michael Salbaum PhD, Jaroslaw Staszkiewicz PhD, Robbie Beyl PhD, Sujoy Ghosh PhD, Susan J. Burke PhD, J. Jason Collier PhD … See fewer authorsÂ
doi : 10.1111/dom.15522
The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
Wissam Ghusn MD, Sima Fansa MD, Diego Anazco MD, Elif Tama MD, Lizeth Cifuentes MD, Khushboo Gala MBBS, Alan De La Rosa MD, Daniel Sacoto MD, Alejandro Campos MD, Fauzi Feris MD, Daniela Hurtado MD, Andres Acosta MD
doi : 10.1111/dom.15523
Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
Chunyan Hu, Shuangyuan Wang, Hong Lin, Qin Wan, Ruizhi Zheng, Yuanyue Zhu, Mian Li PhD, Yu Xu PhD, Min Xu PhD, Jie Zheng PhD, Lulu Chen PhD, Tianshu Zeng PhD, Ruying Hu MPH, Zhen Ye MPH, Lixin Shi MD, Qing Su MD, Yuhong Chen PhD, Xuefeng Yu PhD, Li Yan PhD, Tiange Wang PhD, Zhiyun Zhao PhD, Guijun Qin PhD, Gang Chen PhD, Meng Dai BS, Di Zhang BS, Xulei Tang PhD, Zhengnan Gao PhD, Feixia Shen PhD, Xuejiang Gu PhD, Zuojie Luo PhD, Yingfen Qin PhD, Li Chen PhD, Xinguo Hou PhD, Yanan Huo MD, Qiang Li PhD, Guixia Wang PhD, Yinfei Zhang PhD, Chao Liu MD, Youmin Wang PhD, Shengli Wu MD, Tao Yang PhD, Huacong Deng PhD, Jiajun Zhao PhD, Yiming Mu MD, Shenghan Lai PhD, Donghui Li PhD, Guang Ning PhD, Weiqing Wang MD, Weiguo Hu MD, Yufang Bi MD, Jieli Lu MD, for the 4C Study Group
doi : 10.1111/dom.15525
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Soo Lim MD, Seung-Hwan Lee MD, Kyung-Wan Min MD, Chang Beom Lee MD, Sang Yong Kim MD, Hye Jin Yoo MD, Nan Hee Kim MD, Jae Hyeon Kim MD, Seungjoon Oh MD, Jong Chul Won MD, Hyuk Sang Kwon MD, Mi Kyung Kim MD, Jung Hwan Park MD, In-Kyung Jeong MD, Sungrae Kim MD
doi : 10.1111/dom.15526
Associations of diabesity with all-cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study
Fanny Petermann-Rocha PhD, Evelia Apolinar BSc, Gabriela Nazar PhD, Felipe Diaz-Toro MSc, Andrés Celis PhD, Salil Deo MD, Gerson Ferrari PhD, Gary O'Donovan PhD
doi : 10.1111/dom.15528
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
Frederick Berro Rivera MD, Grace Nooriza O. Lumbang MD, Danielle Rose Magno Gaid MD, Linnaeus Louisse A. Cruz MD, John Vincent Magalong MD, Nathan Ross B. Bantayan BSc, Kyla M. Lara-Breitinger MD, Martha Gulati MD, George Bakris MD
doi : 10.1111/dom.15529
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Marga A. G. Helmink MD, Steven H. J. Hageman PhD, Björn Eliasson PhD, Naveed Sattar PhD, Frank L. J. Visseren PhD, Jannick A. N. Dorresteijn PhD, Katie Harris PhD, Sanne A. E. Peters PhD, Mark Woodward PhD, Péter Szentkúti MSc, Kurt Højlund PhD, Jan Erik Henriksen PhD, Henrik Toft Sørensen PhD, Erik H. Serné PhD, Thomas T. van Sloten PhD, Reimar W. Thomsen PhD, Jan Westerink PhD
doi : 10.1111/dom.15531
Ingesting probiotic yogurt containing Lactiplantibacillus plantarum OLL2712 improves glycaemic control in adults with prediabetes in a randomized, double-blind, placebo-controlled trial
Takayuki Toshimitsu PhD, Ayako Gotou BS, Toshihiro Sashihara PhD, Kenichi Hojo PhD, Satoshi Hachimura PhD, Nobuhiko Shioya PhD, Yoshitaka Iwama MD, Junichiro Irie MD, Yoshitatsu Ichihara PhD
doi : 10.1111/dom.15534
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study
Tae Seo Sohn MD, Kyung-Ah Han MD, Yonghyun Kim MD, Byung-Wan Lee MD, Suk Chon MD, In-Kyung Jeong MD, Eun-Gyoung Hong MD, Jang Won Son MD, JaeJin Na BS, Jae Min Cho PhD, Seong In Cho MS, Wan Huh MS, Kun-Ho Yoon MD
doi : 10.1111/dom.15537
The GPR40 novel agonist SZZ15-11 improves non-alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet-induced obese mice
Lei Lei PhD, Xuefeng Gao MS, Jiayu Zhai MS, Shuainan Liu PhD, Quan Liu PhD, Caina Li PhD, Hui Cao PhD, Cunyu Feng MS, Leilei Chen MS, Liran Lei MS, Xuan Pan PhD, Pingping Li PhD, Zhanzhu Liu PhD, Yi Huan PhD, Zhufang Shen BS
doi : 10.1111/dom.15539
Effects of home-based exergaming on cardio-metabolic and cognitive health in physically inactive individuals
Andreas Melmer PhD, Anna Lisa Martin-Niedecken PhD, Wanda Wehrli, Patrick Lüchinger, Yanick Riederer MSc, Sam Scott PhD, Jordan Pickles MPhil, Stephan Niedecken Dipl, David Flagmeier BA, Stephan Villiger BSc, Roman Jurt BA, Nicole Kind Dipl, Lilian Witthauer PhD, Alexandra Schättin PhD, Christoph Stettler MD
doi : 10.1111/dom.15540
Sex-specific associations between haemoglobin glycation index and the risk of cardiovascular and all-cause mortality in individuals with pre-diabetes and diabetes: A large prospective cohort study
Jingqi Yang MD, Qing Shangguan MD, Guobo Xie MD, Ming Yang MD, Guotai Sheng MD
doi : 10.1111/dom.15541
Analyses of potential causal contributors to increased waist/hip ratio-associated cardiometabolic disease: A combined and sex-stratified Mendelian randomization study
Habiba Hashemy MD, Anthony Nguyen BSc, Rana Khafagy MSc, Delnaz Roshandel PhD, Andrew D. Paterson MBBS, Satya Dash MBBS
doi : 10.1111/dom.15542
Efficacy of topiramate in reducing second-generation antipsychotic-associated weight gain among children: A systematic review and meta-analysis
Gabriel P. A. Costa, Vitor R. Y. Moraes, Beatriz R. Assunção MD, Nora Burns DO, Sobia Laique MD, Shreya Sengupta MD, Akhil Anand MD, Julio C. Nunes MD
doi : 10.1111/dom.15543
Hydrogel dressings for diabetic foot ulcer: A systematic review and meta-analysis
Hongjiao Zhao, You Wu MS, Yuchen Xie MS, Yanfei Li, Chen Chen MS, Chanjuan Li MS, Fangzheng Yang, Deteng Zhang PhD, Yaqin Wang PhD, Junhua Yuan PhD
doi : 10.1111/dom.15544
The association between body mass index and health-related quality of life in the 2017 and 2018 health survey of England data: A cross-sectional observational analysis
Xiao Wen Luah MSc, Thomas Holst-Hansen PhD, Christopher Lübker PhD
doi : 10.1111/dom.15546
Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study
Minying Peng MMed, Siyao He MD, Jinping Wang MD, Yali An MD, Xin Qian MD, Bo Zhang MD, Lihong Zhang MD, Bo Chen MPH, Zhiwei Yang MD, Guangwei Li MD, Qiuhong Gong MD, for the Da Qing Diabetes Prevention Outcome Study Group … See fewer authorsÂ
doi : 10.1111/dom.15547
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice
Yuichiro Iwamoto MD, Tomohiko Kimura MD, Kazunori Dan MD, Hideyuki Iwamoto MD, Junpei Sanada MD, Yoshiro Fushimi MD, Yukino Katakura MD, Masashi Shimoda MD, Yuka Nogami MSc, Yoshiko Shirakiya MMSc, Shuhei Nakanishi MD, Tomoatsu Mune MD, Kohei Kaku MD, Hideaki Kaneto MD
doi : 10.1111/dom.15548
Could poor glycaemic control be a predictor of walking speed decline in older adults? Evidence from the English Longitudinal Study of Ageing
Mariane M. Luiz MSc, Roberta de O. Máximo PhD, Dayane C. de Oliveira PhD, Paula C. RamÃrez PhD, Aline F. de Souza MSc, Maicon L. B. Delinocente Msc, Natália Cochar-Soares MSc, Andrew Steptoe PhD, Cesar de Oliveira PhD, Tiago da S. Alexandre PhD
doi : 10.1111/dom.15549
Intra-pancreatic fat is associated with continuous glucose monitoring metrics
Yutong Liu MHSc, Wandia Kimita PhD, Xiatiguli Shamaitijiang MHSc, Loren Skudder-Hill MHSc, Ivana R. Sequeira-Bisson PhD, Maxim S. Petrov PhD
doi : 10.1111/dom.15550
The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection
Leo Thomas PhD, Eric Martel PhD, Wolfgang Rist PhD, Ingo Uphues PhD, Dieter Hamprecht PhD, Heike Neubauer PhD, Robert Augustin PhD
doi : 10.1111/dom.15551
Maladaptive response following glucose overload in GLUT4-overexpressing H9C2 cardiomyoblasts
Bernd Stratmann PhD, Britta Eggers PhD, Yvonne Mattern, Tayana Silva de Carvalho PhD, Katrin Marcus-Alic PhD, Diethelm Tschoepe MD
doi : 10.1111/dom.15553
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
Gian Paolo Fadini MD, Benedetta Maria Bonora MD, Mariangela Ghiani MD, Roberto Anichini MD, Elena Melchionda MD, Bruno Fattor MD, Stefano Fazion MD, Giancarla Meregalli MD, Andrea Giaccari MD, Angelo Avogaro MD, Agostino Consoli MD, the GLIMPLES study investigators
doi : 10.1111/dom.15554
The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis
Yu Zhang MD, Danning Yang MD, Qiufeng Jia MD, Jie Yan MD, Fengshuang An MD
doi : 10.1111/dom.15557
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study
Elena A. Christofides MD, Orlando Puente MD, Paul Norwood MD, Douglas Denham DO, Hiralal Maheshwari MD, Michael Lillestol MD, Terence Hart MD, Samer Nakhle MD, Anurekha Chadha PhD, David Fitz-Patrick MD, Danny Sugimoto MD, Joseph Soufer MD, Douglas Young MD, Mark Warren MD, David Huffman MD, John Reed MD, Harold Bays MD, Samir Arora MD, Barbara Rizzardi MD, Raymond Tidman MD, Marc Rendell MD, Kimball A. Johnson MD
doi : 10.1111/dom.15560
Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study
Yuta Suzuki PhD, Hidehiro Kaneko MD, Hajime Nagasawa MD, Akira Okada MD, Katsuhito Fujiu MD, Taisuke Jo MD, Norifumi Takeda MD, Hiroyuki Morita MD, Akira Nishiyama MD, Tomohito Gohda MD, Yusuke Suzuki MD, Koichi Node MD, Hideo Yasunaga MD, Masaomi Nangaku MD, Issei Komuro MD
doi : 10.1111/dom.15561
During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range
Mari-Anne Pulkkinen MD, Tero J. Varimo MD, Elina T. Hakonen MD, Matti T. Hero MD, Päivi J. Miettinen MD, Anna-Kaisa Tuomaala MD
doi : 10.1111/dom.15562
Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial
Nawaz Z. Safdar MBChB, Anwar M. Alobaid MSc, Mark Hopkins PhD, Paddy C. Dempsey PhD, Sam M. Pearson MBBS, Noppadol Kietsiriroje, Rachel Churm PhD, Ramzi A. Ajjan MD, Matthew D. Campbell PhD … See fewer authorsÂ
doi : 10.1111/dom.15564
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes
Bertrand Cariou MD, Jennifer Linge PhD, Ian J. Neeland MD, Olof Dahlqvist Leinhard PhD, Mikael Petersson PhD, Laura Fernández Landó MD, Ross Bray PhD, Ã�ngel RodrÃguez MD
doi : 10.1111/dom.15566
Evaluating the global impact of low physical activity on type 2 diabetes: Insights from the global burden of disease 2019 study
Juan Luo MD, Xinlan Zhao MD, Qianru Li MD, Binbin Zou MD, Wen Xie MD, Yanjun Lei MD, Jinglin Yi MD, Chi Zhang MD
doi : 10.1111/dom.15568
TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes
Snežana Milanović MD, Nina Dedic PhD, Robert Lew PhD, Duane Burton MHA, Kenneth S. Koblan PhD, Michael Camilleri MD, Seth C. Hopkins PhD
doi : 10.1111/dom.15569
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery
Henri Honka MD, Amalia Gastaldelli PhD, Samantha Pezzica MS, Richard Peterson MD, Ralph DeFronzo MD, Marzieh Salehi MD
doi : 10.1111/dom.15570
Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium-glucose cotransporter-2 inhibitors versus other medications: A systematic review and meta-analysis of observational cohort studies
Anna Hodgson MD, Clare L. Gillies PhD, Patrick Highton PhD, Louise Haddon MSc, Safoora Gharibzadeh PhD, Francesco Zaccardi PhD, Kamlesh Khunti MD
doi : 10.1111/dom.15571
Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems
Lauren V. Turner MSc, Michael C. Riddell PhD
doi : 10.1111/dom.15532
Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
Djordje S. Popovic PhD, Dimitrios Patoulias PhD, Paschalis Karakasis MSc, Theocharis Koufakis PhD, Nikolaos Papanas PhD
doi : 10.1111/dom.15535
Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes
Esben Iversen MD, Katrine McLain Christensen MSc, Anne Byriel Walls PhD, Mie Klessen Eickhoff PhD, Bernt Johan von Scholten MD, Marie Frimodt-Møller MD, Tine Willum Hansen MD, Frederik Persson MD, Peter Rossing MD, Viktor Rotbain Curovic MD, Morten Baltzer Houlind PhD … See fewer authorsÂ
doi : 10.1111/dom.15536
Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials
Giovanni Antonio Silverii MD, Christian Marinelli MD, Edoardo Mannucci MD, Francesco Rotella MD
doi : 10.1111/dom.15538
Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes
Thomas Nyström PhD, Mikael Andersson Franko PhD, Johnny Ludvigsson PhD, Marcus Lind PhD, Martina Persson PhD
doi : 10.1111/dom.15545
Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study
Chenyang Shi PharmD, Yijiong Tan MPharm, Shanshan Hu MPharm, Yingyi Qin PharmD, Yuanjun Tang MPharm, Yufan Wang PharmD, Guorong Fan PharmD
doi : 10.1111/dom.15552
Personalizing cardiovascular risk: Coronary artery calcium scans to improve statin use in adults with type 2 diabetes can be cost-effective in select individuals
Darren Lau MD, Glen J. Pearson PharmD, Paolo Raggi MD, Scott Klarenbach MD
doi : 10.1111/dom.15558
Digital healthcare solutions to better achieve the weight loss outcomes expected by payors and patients
Louis Talay PhD, Omar Alvi MD
doi : 10.1111/dom.15513
Correction to ‘In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank’
doi : 10.1111/dom.15591
